Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Xiang‐Qin Weng"'
Autor:
Meng-Ke Liu, Feng Liu, Yu-Ting Dai, Xiang-Qin Weng, Li-Li Cheng, Li-Quan Fan, Han Liu, Lu Jiang, Xiao-Jian Sun, Hai Fang, Li Wang, Wei-Li Zhao
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Mast cell leukemia is a rare and aggressive disease, predominantly with KIT D816V mutation. With poor response to conventional poly-chemotherapy, mast cell leukemia responded to the midostaurin treatment with a 50% overall response rate (ORR), but co
Externí odkaz:
https://doaj.org/article/7bccce04824d4586b259c41c50bfc365
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Midostaurin combined with chemotherapy is currently used to treat newly diagnosed acute myeloid leukemia (AML) patients with FMS-like tyrosine kinase 3 (FLT3)-mutations. However, midostaurin acts as an antagonist to some chemother
Externí odkaz:
https://doaj.org/article/4f8516d102b64a7e81af97faffdbb53d
Autor:
Rui Sun, Pei-Pei Zhang, Xiang-Qin Weng, Xiao-Dong Gao, Chuan-Xin Huang, Li Wang, Xiao-Xia Hu, Peng-Peng Xu, Lin Cheng, Lu Jiang, Di Fu, Bin Qu, Yan Zhao, Yan Feng, Hong-Jing Dou, Zhong Zheng, Wei-Li Zhao
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-14 (2022)
Abstract MicroRNAs (miRNAs) are involved in lymphoma progression by regulating the tumor microenvironment. Serum miR130b is overexpressed in diffuse large B-cell lymphoma (DLBCL), inducing Th17 cell alterations. To further illustrate its biological s
Externí odkaz:
https://doaj.org/article/d6b24e9f9a9e4e5baadbae226d462f11
Autor:
Hao Zhang, Nuo Cheng, Zhihui Li, Ling Bai, Chengli Fang, Yuwen Li, Weina Zhang, Xue Dong, Minghao Jiang, Yang Liang, Sujiang Zhang, Jianqing Mi, Jiang Zhu, Yu Zhang, Sai‐Juan Chen, Yajie Zhao, Xiang‐Qin Weng, Weiguo Hu, Zhu Chen, Jinyan Huang, Guoyu Meng
Publikováno v:
Cancer Communications, Vol 41, Iss 11, Pp 1116-1136 (2021)
Abstract Background Abnormal alternative splicing is frequently associated with carcinogenesis. In B‐cell acute lymphoblastic leukemia (B‐ALL), double homeobox 4 fused with immunoglobulin heavy chain (DUX4/IGH) can lead to the aberrant production
Externí odkaz:
https://doaj.org/article/7fca2b2f3c82432b857e2e6044af3125
Autor:
Zhong Zheng, Rui Sun, Hui-Jin Zhao, Di Fu, Hui-Juan Zhong, Xiang-Qin Weng, Bin Qu, Yan Zhao, Li Wang, Wei-Li Zhao
Publikováno v:
Molecular Cancer, Vol 18, Iss 1, Pp 1-13 (2019)
Abstract Background MicroRNAs (miRs) are involved in lymphoma progression by regulating tumor cell interaction with microenvironment. MiR155 is overexpressed in diffuse large B-cell lymphoma (DLBCL) and its biological effect on tumor microenvironment
Externí odkaz:
https://doaj.org/article/971e97f611a949b7ae142d49c764c7cf
Autor:
Zhong Zheng, Peng-Peng Xu, Li Wang, Hui-Jin Zhao, Xiang-Qin Weng, Hui-Juan Zhong, Bin Qu, Jie Xiong, Yan Zhao, Xue-Feng Wang, Anne Janin, Wei-Li Zhao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-10 (2017)
Abstract Background MicroRNAs (miRs) are involved in tumor progression by regulating tumor cells and tumor microenvironment. MiR21 is overexpressed in diffuse large B-cell lymphoma (DLBCL) and its biological impact on tumor microenvironment remains u
Externí odkaz:
https://doaj.org/article/01e5439bff07438eb93a11c1a00b7ac6
Autor:
Yuan-Fang Liu, Bai-Yan Wang, Wei-Na Zhang, Jin-Yan Huang, Ben-Shang Li, Ming Zhang, Lu Jiang, Jian-Feng Li, Ming-Jie Wang, Yu-Jun Dai, Zi-Guan Zhang, Qiang Wang, Jie Kong, Bing Chen, Yong-Mei Zhu, Xiang-Qin Weng, Zhi-Xiang Shen, Jun-Min Li, Jin Wang, Xiao-Jing Yan, Yan Li, Ying-Min Liang, Li Liu, Xie-Qun Chen, Wang-Gang Zhang, Jin-Song Yan, Jian-Da Hu, Shu-Hong Shen, Jing Chen, Long-Jun Gu, Deqing Pei, Yongjin Li, Gang Wu, Xin Zhou, Rui-Bao Ren, Cheng Cheng, Jun J. Yang, Kan-Kan Wang, Sheng-Yue Wang, Jinghui Zhang, Jian-Qing Mi, Ching-Hon Pui, Jing-Yan Tang, Zhu Chen, Sai-Juan Chen
Publikováno v:
EBioMedicine, Vol 8, Iss C, Pp 173-183 (2016)
Genomic landscapes of 92 adult and 111 pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL) were investigated using next-generation sequencing and copy number alteration analysis. Recurrent gene mutations and fusions were tested in an
Externí odkaz:
https://doaj.org/article/13f2b015a60a4c56b66f1473c018a978
Autor:
Jian-Feng Li, Wen-Yan Cheng, Xiang-Jie Lin, Li-Jun Wen, Kai Wang, Yong-Mei Zhu, Hong-Ming Zhu, Xin-Jie Chen, Yu-Liang Zhang, Wei Yin, Jia-Nan Zhang, Xiao Yi, Fan Zhang, Xiang-Qin Weng, Sheng-Yue Wang, Lu Jiang, Hui-Yi Wu, Jia-Qi Ren, Xiao-Jing Lin, Niu Qiao
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 3/5/2024, Vol. 121 Issue 10, p1-12, 52p
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 23:1074-1084
Background and objective: All-trans retinoic acid (ATRA) is only effective in acute promyelocytic leukemia (APL), but not in other subtype of acute myeloid leukemia (AML). Salinomycin targets tumor cells rather than non-tumorigenic cells, and WNT/β-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b40bed6add5ea73afbd78d7445260520
https://doi.org/10.2174/1871520623666230110121629
https://doi.org/10.2174/1871520623666230110121629
Supplementary Figure 1. TWIST1 was highly expressed in APL cells. Supplementary Figure 2. High TWIST1 expression promotes APL progression. Supplementary Figure 3. TRIB3 interacts with TWIST1 in APL cells. Supplementary Figure 4. TRIB3 inhibition prom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b56fb2778f337367a4d45bc45b508d6
https://doi.org/10.1158/1078-0432.22471961
https://doi.org/10.1158/1078-0432.22471961
